Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Breaking News

Israel Admits Birth Control Program for Ethiopians

A government official has for the first time acknowledged the practice of injecting women of Ethiopian origin with the long-acting contraceptive Depo-Provera.

Health Ministry Director General Prof. Ron Gamzu has instructed the four health maintenance organizations to stop the practice as a matter of course. The ministry and other state agencies had previously denied knowledge or responsibility for the practice, which was first reported five years ago. Gamzu’s letter instructed “all gynecologists in the HMOs not to renew prescriptions for Depo-Provera for women of Ethiopian origin if for any reason there is concern that they might not understand the ramifications of the treatment.” Gamzu also instructed physicians to avail themselves of translators if need be.

Gamzu’s letter came in response to a letter from Sharona Eliahu-Chai of the Association of Civil Rights in Israel, representing several women’s rights and Ethiopian immigrants’ groups. The letter demanded the injections cease immediately and that an investigation be launched into the practice.

For more go to Haaretz.com

Engage

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.